A phase 2, prospective, multicenter, double-blind, randomized study of saroglitazar magnesium 1 mg, 2 mg or 4 mg versus placebo in patients with nonalcoholic fatty liver disease and/or nonalcoholic steatohepatitis (EVIDENCES IV) [abstract L010]
10.1073/pnas.0630588100 38 LopaschukG
In controlled laboratory conditions, it may be included in experimental studies examining peptide stability, structural characteristics, and molecular interaction behavior
Diet and endometriosis-revisiting the linkages to inflammation
3.1.2.5 SIRT5 SIRT5 is a pivotal enzyme that promotes metabolic homeostasis, inhibiting mitochondrial fission and degradation processes, reducing the susceptibility of the mitochondria to oxidative stress-induced mitochondrial dysfunction